<DOC>
	<DOCNO>NCT00096473</DOCNO>
	<brief_summary>Donepezil hydrochloride ( Aricept ) approve treat symptom associate mild moderate Alzheimer 's disease ( AD ) . Aricept show improve memory think ability , activity daily live global function patient . The purpose study investigate effectiveness safety donepezil patient severe Alzheimer 's disease . Donepezil think work brain increase level important brain chemical call acetylcholine . This chemical help person 's memory work well .</brief_summary>
	<brief_title>Efficacy Safety Aricept Treatment Severe Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Clinically diagnose Alzheimer 's Disease MMSE score 1~12 Have treat medication Alzheimer 's Disease past 3 month Live community Assisted Living Facility Healthy chronic disease medically control stabilize Able swallow tablet Any primary neurological psychiatric diagnosis ( include depressive disorder ) Alzheimer 's Disease Dementia cause organic disease Alzheimer 's Disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>dementia</keyword>
	<keyword>acetylcholinesterase</keyword>
	<keyword>donepezil</keyword>
	<keyword>Aricept</keyword>
	<keyword>memory loss</keyword>
	<keyword>Severe dementia Alzheimer 's type</keyword>
</DOC>